ARCT Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.